---
title: Pharmacological treatment of depression in patients with brain tumors
date: '2024-06-29'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38943227/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240630182643&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Patients with brain tumors suffer from intense psychosocial distress.
  Although the prevalence of depressive symptoms in patients with brain tumors is
  high, the pharmacological antidepressant treatment of those patients is not well
  defined and results from clinical trials are largely missing. In this review, we
  describe the current standard of evidence and clinical guidelines for the pharmacological
  treatment of depression in brain tumor patients. We present specific side effects
  and ...
disable_comments: true
---
Patients with brain tumors suffer from intense psychosocial distress. Although the prevalence of depressive symptoms in patients with brain tumors is high, the pharmacological antidepressant treatment of those patients is not well defined and results from clinical trials are largely missing. In this review, we describe the current standard of evidence and clinical guidelines for the pharmacological treatment of depression in brain tumor patients. We present specific side effects and ...